DART partners GE Healthcare and Optellum announced that they have signed a letter of intent to collaborate to advance precision diagnosis and treatment of lung cancer. GE Healthcare is a global leader in medical imaging solutions. Optellum is the leader in AI decision support for the early diagnosis and optimal treatment of lung cancer.
A clinician’s AI-assisted diagnosis of malignancy may enable patients whose nodules are not malignant to avoid unnecessary and aggressive procedures such as biopsy and surgical resection, while expediting the diagnostic process, and enabling the right treatment to start earlier. This has the potential to provide patients with personalized diagnosis and treatment plans, enabling lung cancer patients to be treated at the earliest possible stage when survival rates are the highest. This is also the ambition of DART.
Read the full press release here.
NCIMI: Seven Strategies for Success – for adoption and deployment of Artificial Intelligence in Medical Diagnostics
November 25, 2021
NCIMI, working with The Behavioural Architects have created a guide to support their ambition of driving greater adoption of AI within the…
Automated Annotator: Capturing Expert Knowledge
October 27, 2021
DART presentation at Machine Learning in Medical Imaging workshop
September 27, 2021
AI software could help clinicians diagnose lung cancer earlier and reduce waiting lists for patients
July 26, 2021